Advisory Council on the Misuse of Drugs. (2020) Synthetic cannabinoid receptor agonists (SCRA). An updated harms assessment and a review of classification and scheduling under the Misuse of Drugs Act 1971 and its Regulations. London: Advisory Council on the Misuse of Drugs.
Preview | Title | Contact |
---|---|---|
|
PDF (Synthetic cannabinoid receptor agonists (SCRA))
- Published Version
743kB |
Synthetic cannabinoid receptor agonists (SCRA) are chemicals that stimulate the endogenous cannabinoid receptors within the body responsible for mediating the pharmacological effects of tetrahydrocannabinol (THC), the major active ingredient of cannabis. They are sometimes referred to as synthetic cannabinoids, but this term is misleading, as some examples are not structurally related to naturally occurring cannabinoid compounds. The first examples of SCRA were created in the 1980s to research cannabinoid receptor pharmacology and to explore the therapeutic potential of drugs interacting with the cannabinoid receptor system.
B Substances > New (novel) psychoactive substances > Synthetic cannabinoids (Spice / K2 / OXIZID / HHC)
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
L Social psychology and related concepts > Legal availability or accessibility
MM-MO Crime and law > Substance use laws > Drug laws
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
VA Geographic area > Europe > United Kingdom
Repository Staff Only: item control page